Update On Q4 Pivot View For Stocks And Gold
Stock Market Status In our August 11 article Potential Pivots Upcoming for Stocks and Gold, we noted several legs that could be kicked out from under the S&P 500’s table in Q4 2017. The stock market blew right through one of them, which was a bearish (on average) seasonal trend for the 2nd half of […]
The Curious Case Of Missing The Market Boom
Rembrandt Old man with a beard 1630 “The Cost of Missing the Market Boom is Skyrocketing”, says a Bloomberg headline today. That must be the scariest headline I’ve seen in quite a while. For starters, it’s misleading, because people who ‘missed’ the boom haven’t lost anything other than virtual wealth, which is also the only thing those […]
One Brilliant Thing Is Way Better Than 1000 Average Ones
I’ve blogged on some of the themes I’m going to cover below, but the story gets clearer and clearer in my head the more I blog about and talk about it, so this version may be a little clearer than some that have gone before. The first is that banks’ organisational structures have to move […]
The Donald Can’t Stop It
The Dow’s march onward and upward toward 30,000 continues without a pause. New all-time highs are notched practically every day. Despite Thursday’s 31-point pullback, the Dow is up over 15.5 percent year-to-date. What a remarkable time to be alive. The DJIA keeps surging… but it is running on fumes (US money supply growth is disappearing […]
Q3 Earnings Season Kicks Off: 4 Housing Picks
The current housing scenario doesn’t seem all that rosy with housing data for the July-August period showing dismal growth. Of late, the industry has been dealing with a shortage in inventory which is raising prices in several parts of the country. Meanwhile, the devastating Harvey and Irma hurricanes created uncertainties for builders. This, along with […]
‘I Ought To Know Better’: Jim Grant Apologizes For Suggesting Bridgewater Is Fishy
On Wednesday, we noted that according to his latest newsletter, Jim Grant is bearish on Ray Dalio. And Jim’s reasoning is pretty straightforward: Activities [like] tweeting, promoting his book, attacking the press have one thing in common: They are not investing. Yet here he is, laying it all out to the world again – necessarily doing less of his day […]
Concern Over Valeant’s Financial Controls ‘Likely Just Noise,’ Says Cantor
Cantor Fitzgerald analyst Louise Chen says she’s received calls today regarding concerns about Valeant Pharmaceuticals’ (VRX) financial controls. As reported last night by The Fly, Wells Fargo analyst David Maris expressed concern over Valeant’s controls after digging into the lawsuit from Depomed (DEPO). The shares in afternoon trading are down 4%, or 53c, to $13.32. […]
